nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A great Russian scientist has died
|
|
|
|
12 |
11 |
p. 1499-1503 |
artikel |
2 |
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma
|
Blanke, C.D. |
|
|
12 |
11 |
p. 1575-1580 |
artikel |
3 |
A phase II study of irinotecan with 5-fluorouracil and leucovorinin patients with previously untreated gastric adenocarcinoma
|
C. D. Blanke |
|
2001 |
12 |
11 |
p. 1575-1580 6 p. |
artikel |
4 |
A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients
|
Huisman, C. |
|
|
12 |
11 |
p. 1567-1573 |
artikel |
5 |
A phase I study of sequential intravenous topotecan and etoposidein lung cancer patients
|
C. Huisman |
|
2001 |
12 |
11 |
p. 1567-1573 7 p. |
artikel |
6 |
Appointment
|
Kerr, David |
|
|
12 |
11 |
p. 1499-1503 |
artikel |
7 |
B. D. Cheson (ed), Monoclonal Antibody Therapy of Hematologic Malignancies
|
A. Engert |
|
2001 |
12 |
11 |
p. 1504-1504 1 p. |
artikel |
8 |
Book review
|
Aebi, S. |
|
|
12 |
11 |
p. 1654 |
artikel |
9 |
Book review
|
Engert, A. |
|
|
12 |
11 |
p. 1504 |
artikel |
10 |
Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation
|
Picci, P. |
|
|
12 |
11 |
p. 1601-1604 |
artikel |
11 |
Computed tomography of pulmonary metastases from osteosarcoma:The less poor technique. A study of 51 patients withhistological correlation
|
P. Picci |
|
2001 |
12 |
11 |
p. 1601-1604 4 p. |
artikel |
12 |
Contents of the next issue
|
|
|
|
12 |
11 |
p. iv |
artikel |
13 |
Copyright
|
|
|
|
12 |
11 |
p. ii |
artikel |
14 |
Dietary glycemic index and glycemic load, and breast cancer risk: A case-control study
|
Augustin, L.S.A. |
|
|
12 |
11 |
p. 1533-1538 |
artikel |
15 |
Dietary glycemic index and glycemic load, and breast cancer risk:A case-control study
|
L. S. A. Augustin |
|
2001 |
12 |
11 |
p. 1533-1538 6 p. |
artikel |
16 |
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer
|
Fogli, S. |
|
|
12 |
11 |
p. 1553-1559 |
artikel |
17 |
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer
|
S. Fogli |
|
2001 |
12 |
11 |
p. 1553-1559 7 p. |
artikel |
18 |
Editorial Board
|
|
|
|
12 |
11 |
p. iii |
artikel |
19 |
Evaluation and appraisal of randomized controlled trials in myeloma
|
B. Djulbegovic |
|
2001 |
12 |
11 |
p. 1611-1617 7 p. |
artikel |
20 |
Evaluation and appraisal of randomized controlled trials in myeloma* * Presented at the 36th American Society of Clinical Oncology Meeting, New Orleans, May 20–23, 2001
|
Djulbegovic, B. |
|
|
12 |
11 |
p. 1611-1617 |
artikel |
21 |
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?
|
Carlini, P. |
|
|
12 |
11 |
p. 1539-1543 |
artikel |
22 |
Formestane, a steroidal aromatase inhibitor after failure ofnon-steroidal aromatase inhibitors (anastrozole and letrozole): Is aclinical benefit still achievable?
|
P. Carlini |
|
2001 |
12 |
11 |
p. 1539-1543 5 p. |
artikel |
23 |
Gemcitabine-induced systemic capillary leak syndrome
|
De Pas, T. |
|
|
12 |
11 |
p. 1651-1652 |
artikel |
24 |
Gemcitabine-induced systemic capillary leak syndrome
|
T. De Pas |
|
2001 |
12 |
11 |
p. 1651-1652 2 p. |
artikel |
25 |
Glycemic index, hyperinsulinemia, and breast cancer risk
|
Key, T.J. |
|
|
12 |
11 |
p. 1507-1509 |
artikel |
26 |
Glycemic index, hyperinsulinemia, and breast cancer risk
|
T. J. Key |
|
2001 |
12 |
11 |
p. 1507-1509 3 p. |
artikel |
27 |
Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule
|
Schüll, B. |
|
|
12 |
11 |
p. 1653-1654 |
artikel |
28 |
Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule
|
B. Schüll |
|
2001 |
12 |
11 |
p. 1653-1654 2 p. |
artikel |
29 |
In this issue
|
|
|
|
12 |
11 |
p. iv |
artikel |
30 |
J. A. Ledermann, W. J. Hoskins, S. B. Kaye,I. B. Vergote (eds), Clinical Management of Ovarian Cancer
|
S. Aebi |
|
2001 |
12 |
11 |
p. 1654-1654 1 p. |
artikel |
31 |
Localised disease in cancer of unknown primary (CUP): The value of positron emission tomography (PET) for individual therapeutic management
|
Rades, D. |
|
|
12 |
11 |
p. 1605-1609 |
artikel |
32 |
Localised disease in cancer of unknown primary (CUP): The value ofpositron emission tomography (PET) for individualtherapeutic management
|
D. Rades |
|
2001 |
12 |
11 |
p. 1605-1609 5 p. |
artikel |
33 |
Micronutrients and ovarian cancer: A case-control study in Italy
|
Bidoli, E. |
|
|
12 |
11 |
p. 1589-1593 |
artikel |
34 |
Micronutrients and ovarian cancer: A case-control study in Italy
|
E. Bidoli |
|
2001 |
12 |
11 |
p. 1589-1593 5 p. |
artikel |
35 |
More on the benefits of smoking
|
|
|
|
12 |
11 |
p. 1499-1503 |
artikel |
36 |
N-(phosphonacetyl)-l-aspartate and calcium leucovorin modulation offluorouracil administered by constant rate and circadian pattern ofinfusion over 72 hours in metastatic gastrointestinaladenocarcinoma
|
J. L. Grem |
|
2001 |
12 |
11 |
p. 1581-1587 7 p. |
artikel |
37 |
N-(phosphonacetyl)-l-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma* * The US Government’s right to retain a non-exclusive, royalty-free licence in and to any copyright is acknowledged
|
Grem, J.L. |
|
|
12 |
11 |
p. 1581-1587 |
artikel |
38 |
Once again: Natural is not benign
|
|
|
|
12 |
11 |
p. 1499-1503 |
artikel |
39 |
Once again: Natural is not benign • The sorcerers apprentice • Sleep: A need that one should not neglect • Swiss revolution? • More on the benefits of smoking • A great Russian scientist has died • There is no clean war • Appointment • Perhaps not everyone knows that...
|
|
|
2001 |
12 |
11 |
p. 1499-1503 5 p. |
artikel |
40 |
Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors
|
Marty, M. |
|
|
12 |
11 |
p. 1643-1649 |
artikel |
41 |
Oral vinorelbine pharmacokinetics and absolute bioavailabilitystudy in patients with solid tumors
|
M. Marty |
|
2001 |
12 |
11 |
p. 1643-1649 7 p. |
artikel |
42 |
Perhaps not everyone knows that…
|
|
|
|
12 |
11 |
p. 1499-1503 |
artikel |
43 |
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
|
M. L. Rothenberg |
|
2001 |
12 |
11 |
p. 1631-1641 11 p. |
artikel |
44 |
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks* * Preliminary findings of this study were presented at the 10th NC1-EORTC Symposium on New Drugs in Cancer Therapy, 1998
|
Rothenberg, M.L. |
|
|
12 |
11 |
p. 1631-1641 |
artikel |
45 |
Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents
|
Sekine, I. |
|
|
12 |
11 |
p. 1515-1525 |
artikel |
46 |
Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents
|
I. Sekine |
|
2001 |
12 |
11 |
p. 1515-1525 11 p. |
artikel |
47 |
Pre-operative endocrine therapy for postmenopausal women: When and why?
|
Tondini, C. |
|
|
12 |
11 |
p. 1505-1506 |
artikel |
48 |
Pre-operative endocrine therapy for postmenopausal women: When and why?
|
C. Tondini |
|
2001 |
12 |
11 |
p. 1505-1506 2 p. |
artikel |
49 |
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
|
Eiermann, W. |
|
|
12 |
11 |
p. 1527-1532 |
artikel |
50 |
Preoperative treatment of postmenopausal breast cancer patientswith letrozole: A randomized double-blind multicenter study
|
W. Eiermann |
|
2001 |
12 |
11 |
p. 1527-1532 6 p. |
artikel |
51 |
Result of two randomized trials comparing nolatrexed (ThymitaqTM) versus methotrexate in patients with recurrent head and neck cancer
|
X. Pivot |
|
2001 |
12 |
11 |
p. 1595-1599 5 p. |
artikel |
52 |
Result of two randomized trials comparing nolatrexed (Thymitaq™) versus methotrexate in patients with recurrent head and neck cancer
|
Pivot, X. |
|
|
12 |
11 |
p. 1595-1599 |
artikel |
53 |
Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study
|
Paulussen, M. |
|
|
12 |
11 |
p. 1619-1630 |
artikel |
54 |
Second malignancies after Ewing tumor treatment in 690 patientsfrom a cooperative German/Austrian/Dutch study
|
M. Paulussen |
|
2001 |
12 |
11 |
p. 1619-1630 12 p. |
artikel |
55 |
Sleep: A need that one should not neglect
|
|
|
|
12 |
11 |
p. 1499-1503 |
artikel |
56 |
Staging of breast cancer. Is the evidence so evident?
|
Tassinari, D. |
|
|
12 |
11 |
p. 1653 |
artikel |
57 |
Staging of breast cancer. Is the evidence so evident?
|
D. Tassinari |
|
2001 |
12 |
11 |
p. 1653-1653 1 p. |
artikel |
58 |
Swiss revolution?
|
|
|
|
12 |
11 |
p. 1499-1503 |
artikel |
59 |
Table of Contents
|
|
|
|
12 |
11 |
p. i-ii |
artikel |
60 |
Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer
|
Kao, A. |
|
|
12 |
11 |
p. 1561-1566 |
artikel |
61 |
Technetium-99m methoxyisobutylisonitrile chest imaging forsmall-cell lung cancer
|
A. Kao |
|
2001 |
12 |
11 |
p. 1561-1566 6 p. |
artikel |
62 |
There is no ‘clean war’
|
|
|
|
12 |
11 |
p. 1499-1503 |
artikel |
63 |
The sorcerer’s apprentice
|
|
|
|
12 |
11 |
p. 1499-1503 |
artikel |
64 |
Time to consider HPV testing in cervical screening
|
Cuzick, J. |
|
|
12 |
11 |
p. 1511-1514 |
artikel |
65 |
Time to consider HPV testing in cervical screening
|
J. Cuzick |
|
2001 |
12 |
11 |
p. 1511-1514 4 p. |
artikel |
66 |
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer
|
Fountzilas, G. |
|
|
12 |
11 |
p. 1545-1551 |
artikel |
67 |
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer
|
G. Fountzilas |
|
2001 |
12 |
11 |
p. 1545-1551 7 p. |
artikel |